Succinobucol: review of the metabolic, antiplatelet and cardiovascular effects

Author： Muldrew Kendrea M   Franks Amy M  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.18, Iss.4, 2009-04, pp. : 531-539

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Review of the Cardiovascular and Anti-Atherogenic Effects of Ghrelin

By  

Current Pharmaceutical Design, Vol. 19, Iss. 27, 2013-08 ,pp. : 4953-4963

Bentham Science Publishers

Access to resources Recommend Favorite

Metabolic differences of current thienopyridine antiplatelet agents

By Fareed Jawed   Jeske Walter   Thethi Indermohan  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 3, 2013-03 ,pp. : 307-317

Informa Healthcare

Access to resources Recommend Favorite

Antiplatelet Agents for the Prevention of Cardiovascular Disease in Diabetes Mellitus

By Colwell John A.  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 2, 2004-01 ,pp. : 87-106

Adis International

Access to resources Recommend Favorite

Effects of Glucagon-Like Peptide-1 and Long-Acting Analogues on Cardiovascular and Metabolic Function

By Saraceni Christine   Broderick Tom L.  

Drugs in R&D, Vol. 8, Iss. 3, 2007-01 ,pp. : 145-153

Adis International

Access to resources Recommend Favorite

Adverse Metabolic Effects Associated with Atypical Antipsychotics: Literature Review and Clinical Implications

By Melkersson K.  

Drugs, Vol. 64, Iss. 7, 2004-01 ,pp. : 701-723

Adis International

Access to resources Recommend Favorite